Analyst Recommendations

Wedbush analyst issues OUTPERFORM recommendation for TSLA on July 22, 2024 02:12PM ET. The previous analyst recommendation was Outperform.TSLA was trading at $252.38 at issue of the analyst...

July 22, 2024   TSLA -0.24%

Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for GSK on July 22, 2024 01:18PM ET. The previous analyst recommendation was Equal-Weight.GSK was trading at $39.505 at issue of the...

July 22, 2024   GSK -1.62%

Wedbush analyst issues BUY recommendation for RARE on July 22, 2024 12:01PM ET. The previous analyst recommendation was Buy.RARE was trading at $44.01 at issue of the analyst...

July 22, 2024   RARE -4.17%

Goldman Sachs analyst issues BUY recommendation for AXP on July 22, 2024 12:47PM ET. The previous analyst recommendation was Buy.AXP was trading at $243.945 at issue of the...

July 22, 2024   AXP 2.22%

Stephens analyst issues MARKET OUTPERFORM recommendation for NCNO on July 22, 2024 12:01PM ET. The previous analyst recommendation was Market Outperform.NCNO was trading at $33.14 at issue of...

July 22, 2024   NCNO -0.04%

Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for GSK on July 22, 2024 01:18PM ET. The previous analyst recommendation was Equal-Weight.GSK was trading at $39.505 at issue of the...

July 22, 2024   GSK -1.62%

Deutsche Bank analyst issues HOLD recommendation for YARIY on July 22, 2024 01:16PM ET. The previous analyst recommendation was Hold.YARIY was trading at $14.69 at issue of the...

July 22, 2024   YARIY -0.41%

Morgan Stanley analyst issues OVERWEIGHT recommendation for ASHTY on July 22, 2024 01:18PM ET. The previous analyst recommendation was Overweight.ASHTY was trading at $278.37 at issue of the...

July 22, 2024   ASHTY -2.55%

Wedbush analyst issues BUY recommendation for RARE on July 22, 2024 12:01PM ET. The previous analyst recommendation was Buy.RARE was trading at $44.01 at issue of the analyst...

July 22, 2024   RARE -4.17%

CIBC analyst issues NEUTRAL recommendation for HRNNF on July 22, 2024 11:44AM ET. The previous analyst recommendation was Neutral.HRNNF was trading at $29.79 at issue of the analyst...

July 22, 2024   HRNNF -1.17%